|
Market Cap | 2.19B | EPS (ttm) | 0.30 |
P/E | 19.62 | EPS this Y | -7.29% |
Forward P/E | 19.13 | EPS next Y | 37.70% |
PEG | - | EPS past 5Y | - |
P/S | 2.52 | EPS next 5Y | - |
P/B | 3.15 | EPS Q/Q | 275.00% |
Dividend | - | Sales Q/Q | 18.84% |
Insider Own | 23.25% | Inst Own | 62.99% |
Insider Trans | -2.78% | Inst Trans | 1.61% |
Short Float | 4.37% | Earnings | May 08/b |
Analyst Recom | 1.00 | Target Price | 7.50 |
Avg Volume | 2.65M | 52W Range | 4.02 - 6.48 |
|
|
|
Payoneer Global, Inc. is a financial technology company, which engages in providing a financial platform for small and medium-sized businesses to transact and do business. It operates through the Israel, United States, and All Other Countries geographical segments. The company was founded in 2005 and is headquartered in New York, NY. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Zeevi Avi | Director | May 15 '24 | Sale | 5.90 | 2,471 | 14,580 | 427,584 | May 16 08:29 PM | Zeevi Avi | Director | May 14 '24 | Sale | 5.90 | 23,793 | 140,433 | 430,055 | May 16 08:29 PM | Zeevi Avi | Director | May 10 '24 | Sale | 5.90 | 29,354 | 173,247 | 453,848 | May 13 05:00 PM | Zeevi Avi | Director | May 09 '24 | Sale | 5.91 | 10,116 | 59,741 | 483,202 | May 10 04:52 PM | Zeevi Avi | Director | May 08 '24 | Sale | 5.90 | 84,226 | 497,169 | 493,318 | May 10 04:52 PM |
|
|
|
|
Market Cap | 138.70B | EPS (ttm) | 2.39 |
P/E | 32.66 | EPS this Y | 9.00% |
Forward P/E | 17.50 | EPS next Y | 30.74% |
PEG | 2.22 | EPS past 5Y | 0.75% |
P/S | 5.42 | EPS next 5Y | 14.74% |
P/B | 4.17 | EPS Q/Q | -17.90% |
Dividend | 1.31% | Sales Q/Q | 1.35% |
Insider Own | 5.89% | Inst Own | 85.13% |
Insider Trans | -0.97% | Inst Trans | -0.58% |
Short Float | 0.95% | Earnings | Apr 15/b |
Analyst Recom | 1.96 | Target Price | 80.25 |
Avg Volume | 7.08M | 52W Range | 48.66 - 78.79 |
|
|
|
The Charles Schwab Corp. is a savings and loan holding company, which engages in the provision of wealth management, securities brokerage, banking, asset management, custody, and financial advisory services. It operates through the Investor Services and Advisor Services segments. The Investor Services segment includes retail brokerage and banking services to individual investors, and retirement plan services, as well as other corporate brokerage services, to businesses and their employees. The Advisor Services segment provides custodial, trading, retirement business, and support services, as well as retirement business services to independent registered investment advisors, independent retirement advisors, and record keepers. The company was founded by Charles R. Schwab in 1986 and is headquartered in Westlake, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Schwab Charles R. | Co-Chairman | May 15 '24 | Sale | 78.08 | 58,065 | 4,533,709 | 60,683,471 | May 16 08:24 PM | Schwab Charles R. | Co-Chairman | May 14 '24 | Sale | 76.89 | 65,360 | 5,025,700 | 60,741,536 | May 16 08:24 PM | Schwab-Pomerantz Carolyn | Director | May 09 '24 | Sale | 76.13 | 26,315 | 2,003,429 | 1,674,571 | May 13 08:44 PM | Schwab Charles R. | Co-Chairman | May 06 '24 | Sale | 76.40 | 65,790 | 5,026,474 | 60,906,686 | May 08 05:49 PM | Schwab-Pomerantz Carolyn | Director | May 06 '24 | Sale | 76.38 | 13,113 | 1,001,635 | 1,700,886 | May 08 06:10 PM |
|
|
|
|
Market Cap | 22.36B | EPS (ttm) | -0.54 |
P/E | - | EPS this Y | 69.39% |
Forward P/E | 184.64 | EPS next Y | 85.54% |
PEG | - | EPS past 5Y | -4.47% |
P/S | 23.86 | EPS next 5Y | - |
P/B | 24.23 | EPS Q/Q | -103.02% |
Dividend | - | Sales Q/Q | 48.08% |
Insider Own | 66.84% | Inst Own | 28.38% |
Insider Trans | -1.91% | Inst Trans | 3.63% |
Short Float | 6.19% | Earnings | Jun 06/a |
Analyst Recom | 1.86 | Target Price | 41.85 |
Avg Volume | 3.92M | 52W Range | 18.24 - 42.28 |
|
|
|
Samsara, Inc. develops Internet connected sensor systems. It combines plug-and-play sensors, wireless connectivity, and cloud-hosted software integrated for deployment. The company was founded by John Bicket and Sanjit Biswas in 2015 and is headquartered in San Francisco, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Bicket John | SEE REMARKS | May 15 '24 | Sale | 40.28 | 8,216 | 330,952 | 2,132,462 | May 16 07:51 PM | Biswas Sanjit | CHIEF EXECUTIVE OFFICER | May 15 '24 | Sale | 40.27 | 7,944 | 319,871 | 1,680,712 | May 16 08:23 PM | Biswas Sanjit | CHIEF EXECUTIVE OFFICER | May 14 '24 | Sale | 39.89 | 88,056 | 3,512,395 | 1,688,656 | May 16 08:23 PM | Bicket John | SEE REMARKS | May 14 '24 | Sale | 39.89 | 87,784 | 3,501,557 | 2,140,678 | May 16 07:51 PM | Biswas Sanjit | CHIEF EXECUTIVE OFFICER | May 08 '24 | Sale | 37.85 | 24,734 | 936,274 | 153,600 | May 09 05:35 PM |
|
|
| |
|
Market Cap | 2.25B | EPS (ttm) | -2.05 |
P/E | - | EPS this Y | -48.57% |
Forward P/E | 202.35 | EPS next Y | 115.21% |
PEG | - | EPS past 5Y | -76.37% |
P/S | 4.20 | EPS next 5Y | 30.00% |
P/B | 3.67 | EPS Q/Q | 52.97% |
Dividend | - | Sales Q/Q | 24.16% |
Insider Own | 14.28% | Inst Own | 45.56% |
Insider Trans | -3.59% | Inst Trans | -14.33% |
Short Float | 32.22% | Earnings | May 07/a |
Analyst Recom | 4.12 | Target Price | 19.04 |
Avg Volume | 5.12M | 52W Range | 18.75 - 72.58 |
|
|
|
Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. Its platform aggregates consumer demand for loans and connects it to the company's network of artificial intelligence-enabled bank partners. The company was founded by David Joseph Girouard, Anna Mongayt Counselman and Paul Gu in December 2013 and is headquartered in San Mateo, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Gu Paul | Chief Technology Offier | May 15 '24 | Option Exercise | 0.96 | 80,000 | 76,500 | 973,596 | May 16 07:56 PM | Gu Paul | Chief Technology Offier | May 15 '24 | Sale | 29.52 | 80,000 | 2,361,282 | 893,596 | May 16 07:56 PM | Gu Paul | Chief Technology Offier | Apr 01 '24 | Option Exercise | 0.60 | 60,000 | 36,000 | 953,596 | Apr 03 05:23 PM | Gu Paul | Chief Technology Offier | Apr 01 '24 | Sale | 26.31 | 60,000 | 1,578,672 | 893,596 | Apr 03 05:23 PM | Datta Sanjay | Chief Financial Officer | Mar 11 '24 | Sale | 27.50 | 1,000 | 27,500 | 400,536 | Mar 13 05:56 PM |
|
|
|
|
Market Cap | 68.39B | EPS (ttm) | 4.54 |
P/E | 52.07 | EPS this Y | 6.73% |
Forward P/E | 16.60 | EPS next Y | 9.36% |
PEG | 208.28 | EPS past 5Y | 52.43% |
P/S | 3.47 | EPS next 5Y | 0.25% |
P/B | 2.67 | EPS Q/Q | 20.61% |
Dividend | 1.60% | Sales Q/Q | 4.65% |
Insider Own | 0.14% | Inst Own | 88.09% |
Insider Trans | -2.88% | Inst Trans | -1.90% |
Short Float | 0.75% | Earnings | May 02/b |
Analyst Recom | 1.76 | Target Price | 277.42 |
Avg Volume | 1.32M | 52W Range | 229.40 - 287.32 |
|
|
|
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goette Roland | EVP and President EMEA | May 15 '24 | Sale | 236.73 | 3,300 | 781,224 | 11,308 | May 16 07:54 PM | Goette Roland | EVP and President EMEA | May 13 '24 | Sale | 236.70 | 3,300 | 781,121 | 14,608 | May 15 02:44 PM | Garrison Michael David | EVP & President Medical | Apr 30 '24 | Sale | 232.81 | 1,715 | 399,269 | 5,381 | May 01 12:59 PM | Spoerel Thomas J | SVP,Controller&Chief Acct Off | Mar 14 '24 | Sale | 238.29 | 282 | 67,198 | 2,276 | Mar 15 02:19 PM | Garrison Michael David | EVP & President Medical | Dec 11 '23 | Sale | 232.46 | 1,239 | 288,018 | 7,274 | Dec 12 04:31 PM |
|
|
| |
|
Market Cap | 881.79M | EPS (ttm) | -0.52 |
P/E | - | EPS this Y | -21.05% |
Forward P/E | - | EPS next Y | 44.93% |
PEG | - | EPS past 5Y | -1.44% |
P/S | 88179.00 | EPS next 5Y | - |
P/B | 3.93 | EPS Q/Q | 32.81% |
Dividend | - | Sales Q/Q | -100.00% |
Insider Own | 58.35% | Inst Own | 34.68% |
Insider Trans | -0.01% | Inst Trans | 15.32% |
Short Float | 15.81% | Earnings | May 09/a |
Analyst Recom | 1.00 | Target Price | 19.00 |
Avg Volume | 724.26K | 52W Range | 2.55 - 11.27 |
|
|
|
ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Lowenthal Richard E | PRESIDENT AND CEO | May 16 '24 | Sale | 9.06 | 89,096 | 807,023 | 1,597,447 | May 16 07:51 PM | Tanimoto Sarina | CHIEF MEDICAL OFFICER | May 16 '24 | Sale | 9.06 | 89,096 | 807,023 | 1,597,447 | May 16 07:52 PM | Lowenthal Richard E | PRESIDENT AND CEO | May 15 '24 | Sale | 9.05 | 5,147 | 46,565 | 1,642,193 | May 16 07:51 PM | Tanimoto Sarina | CHIEF MEDICAL OFFICER | May 15 '24 | Sale | 9.05 | 5,147 | 46,565 | 1,642,193 | May 16 07:52 PM | Lowenthal Richard E | PRESIDENT AND CEO | May 14 '24 | Sale | 9.01 | 5,757 | 51,854 | 1,644,574 | May 16 07:51 PM |
|
|
|
|
Market Cap | 5.56B | EPS (ttm) | -2.88 |
P/E | - | EPS this Y | 3.40% |
Forward P/E | - | EPS next Y | 40.97% |
PEG | - | EPS past 5Y | -49.95% |
P/S | 17.04 | EPS next 5Y | 8.00% |
P/B | 12.21 | EPS Q/Q | -13.90% |
Dividend | - | Sales Q/Q | 15.86% |
Insider Own | 3.68% | Inst Own | 103.16% |
Insider Trans | -25.69% | Inst Trans | 1.34% |
Short Float | 7.24% | Earnings | May 01/a |
Analyst Recom | 1.53 | Target Price | 112.03 |
Avg Volume | 515.94K | 52W Range | 54.38 - 113.97 |
|
|
|
Glaukos Corp. is an ophthalmic medical technology and pharmaceutical company, which focuses on novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It engages in development and commercialization of therapies across several end markets within ophthalmology. The company was founded by Olav B. Bergheim, Morteza Gharib, and Richard Hill on July 14, 1998 and is headquartered in Aliso Viejo, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Stapley Marc | Director | May 15 '24 | Option Exercise | 32.00 | 6,250 | 200,000 | 38,610 | May 16 07:45 PM | Stapley Marc | Director | May 15 '24 | Sale | 112.80 | 6,250 | 704,993 | 32,360 | May 16 07:45 PM | Gilliam Joseph E | PRESIDENT & COO | May 10 '24 | Option Exercise | 55.18 | 2,395 | 132,156 | 104,240 | May 14 04:43 PM | Gilliam Joseph E | PRESIDENT & COO | May 10 '24 | Sale | 110.56 | 2,395 | 264,791 | 101,845 | May 14 04:43 PM | Thurman Alex R. | SVP & CHIEF FINANCIAL OFFICER | May 10 '24 | Sale | 110.51 | 353 | 39,011 | 51,647 | May 14 04:41 PM |
|
|
| |
|
Market Cap | 124.46M | EPS (ttm) | -1.07 |
P/E | - | EPS this Y | -508.33% |
Forward P/E | - | EPS next Y | 49.68% |
PEG | - | EPS past 5Y | - |
P/S | 0.31 | EPS next 5Y | - |
P/B | 0.38 | EPS Q/Q | -7986.04% |
Dividend | - | Sales Q/Q | 24.10% |
Insider Own | 30.26% | Inst Own | 71.45% |
Insider Trans | -0.16% | Inst Trans | 32.39% |
Short Float | 17.96% | Earnings | May 09/b |
Analyst Recom | 2.71 | Target Price | 4.08 |
Avg Volume | 3.54M | 52W Range | 1.70 - 28.13 |
|
|
|
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Quimi Daphne | Director | May 15 '24 | Buy | 1.89 | 2,250 | 4,252 | 5,000 | May 16 07:37 PM | Mazzariello Gina | Chief Legal Officer | May 15 '24 | Sale | 1.88 | 10,455 | 19,654 | 151,477 | May 16 07:36 PM | Quimi Daphne | Director | May 14 '24 | Buy | 1.89 | 2,750 | 5,184 | 2,750 | May 16 07:37 PM | Klee Justin B. | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 2,959,308 | Mar 07 04:05 PM | Cohen Joshua B | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 3,023,002 | Mar 07 04:05 PM |
|
|
|
|
Market Cap | 1.84B | EPS (ttm) | 3.28 |
P/E | 19.14 | EPS this Y | 14.14% |
Forward P/E | 15.56 | EPS next Y | 7.97% |
PEG | 1.91 | EPS past 5Y | 4.41% |
P/S | 2.29 | EPS next 5Y | 10.00% |
P/B | 4.51 | EPS Q/Q | 110.77% |
Dividend | - | Sales Q/Q | 2.42% |
Insider Own | 5.92% | Inst Own | 92.33% |
Insider Trans | -44.26% | Inst Trans | -4.06% |
Short Float | 4.03% | Earnings | May 01/b |
Analyst Recom | 1.00 | Target Price | 70.50 |
Avg Volume | 211.28K | 52W Range | 41.98 - 66.21 |
|
|
Today 03:17AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $5,313,639, According to a Recent SEC Filing
(MT Newswires) |
May-14-24 09:30AM
|
Wall Street Analysts Think Donnelley Financial (DFIN) Is a Good Investment: Is It?
(Zacks) |
03:26AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $11,626,694, According to a Recent SEC Filing
(MT Newswires) |
May-13-24 05:14PM
|
Full Video Coverage: Readiness and the Road to IPO Panel from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
05:14PM
|
Video Highlights from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
May-10-24 10:05AM
|
Readiness and the Road to IPO Panel from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
May-09-24 03:09AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $35,699,634, According to a Recent SEC Filing
(MT Newswires) |
May-07-24 02:24AM
|
Insider Sale at Donnelley Financial Solutions Inc (DFIN)
(GuruFocus.com) |
May-06-24 05:17PM
|
Donnelley Financial Solutions Insider Sold Shares Worth $1,213,390, According to a Recent SEC Filing
(MT Newswires) |
05:00PM
|
DFIN to Participate in Upcoming Investor Conferences
(PR Newswire) |
|
Donnelley Financial Solutions, Inc. engages in the provision of innovative software and technology-enabled financial regulatory and compliance solutions. It operates through the following segments: Capital Markets-Software Solutions (CM-SS), Capital Markets-Compliance and Communications Management (CM-CCM), Investment Companies-Software Solutions (IC-SS), Investment Companies-Compliance and Communications Management (IC-CCM), and Corporate. The CM-SS segment provides Venue and ActiveDisclosure to public and private companies to help manage public and private transactional and compliance processes, collaborate, and tag, validate, and file SEC documents. The CM-CCM segment offers tech-enabled services and print and distribution solutions to public and private companies for deal solutions and SEC compliance requirements. The IC-SS segment focuses on clients with the Arc Suite platform that contains a comprehensive suite of cloud-based solutions including ArcDigital, ArcReporting, ArcPro, and ArcRegulatory as well as services that enable storage and management of compliance and regulatory information. The IC-CCM segment is involved in turnkey proxy services including discovery, planning and implementation, print and mail management, solicitation, tabulation services, stockholder meeting review, and expert support. The Corporate segment includes unallocated selling, general, and administrative activities and associated expenses including executive, legal, finance, and certain facility costs. The company was founded on February 22, 2016 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Jacobowitz Jeffrey | Director | May 14 '24 | Sale | 61.21 | 86,807 | 5,313,639 | 1,392,985 | May 16 07:35 PM | Jacobowitz Jeffrey | Director | May 13 '24 | Sale | 61.84 | 106,166 | 6,565,305 | 1,479,792 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 10 '24 | Sale | 61.94 | 53,812 | 3,333,156 | 1,585,958 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 09 '24 | Sale | 62.38 | 27,705 | 1,728,232 | 1,639,770 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 08 '24 | Sale | 62.36 | 106,093 | 6,616,191 | 1,667,475 | May 08 08:26 PM |
|
|
|
|
Market Cap | 191.69B | EPS (ttm) | 7.35 |
P/E | 22.26 | EPS this Y | 30.99% |
Forward P/E | 14.61 | EPS next Y | 23.32% |
PEG | 0.88 | EPS past 5Y | 15.59% |
P/S | 2.44 | EPS next 5Y | 25.23% |
P/B | 3.10 | EPS Q/Q | 26.03% |
Dividend | 1.62% | Sales Q/Q | -0.19% |
Insider Own | 62.55% | Inst Own | 39.03% |
Insider Trans | -2.47% | Inst Trans | -1.05% |
Short Float | 5.53% | Earnings | Apr 25/a |
Analyst Recom | 1.50 | Target Price | 186.21 |
Avg Volume | 4.39M | 52W Range | 124.92 - 168.64 |
|
|
|
T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DEUTSCHE TELEKOM AG | Director | May 16 '24 | Sale | 163.22 | 189,670 | 30,958,069 | 675,451,661 | May 16 07:34 PM | DEUTSCHE TELEKOM AG | Director | May 15 '24 | Sale | 162.93 | 189,670 | 30,903,506 | 675,641,331 | May 16 07:34 PM | DEUTSCHE TELEKOM AG | Director | May 14 '24 | Sale | 162.75 | 189,670 | 30,869,188 | 675,831,001 | May 14 06:40 PM | SIEVERT G MICHAEL | President and CEO | May 14 '24 | Sale | 162.84 | 20,000 | 3,256,800 | 438,124 | May 15 05:08 PM | DEUTSCHE TELEKOM AG | Director | May 13 '24 | Sale | 163.19 | 189,670 | 30,952,856 | 676,020,671 | May 14 06:40 PM |
|
|
|